Chronos Archive seal
The Human Record

Edward W. Brooke

Case HR-ML014-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
October 26, 1919 – January 3, 2015
Synthetic DOB
1919-10-26
Index visit
2003-01-13 at age 83
Synthetic MRN
HR-ML014-SYN-TD

Teaching objective: Men get breast cancer. Care for a man of 83 with node-positive, hormone receptor-positive breast cancer after bilateral mastectomy, on the ASCO male breast cancer guideline and the NCCN breast guideline: tamoxifen as the preferred adjuvant endocrine therapy for men (not an aromatase inhibitor alone), with venous thromboembolism, mood, hot flash, sexual side effect, and adherence checks at every visit; germline genetic testing and genetic counseling offered to every man with breast cancer, with information for relatives; bone health on hormone therapy at his age; and survivorship care with no routine imaging or tumor markers. His own public account, that he dismissed his symptoms and had never had his chest examined, frames the teaching on why men present late.

Historical timeline

DateEventClaims
October 26, 1919Born in Washington, D.C.CLM-0001
January 3, 1967Sworn in as U.S. senator from Massachusetts, the first African American elected to the Senate by popular vote.CLM-0002
September 2002Discomfort in the right breast; mammogram, sonogram, and needle biopsy show breast cancer.CLM-0003, CLM-0005
2002Operation for breast cancer (reported as a double mastectomy) with removal of the right-sided lymph nodes.CLM-0004, CLM-0005
June 2003Begins speaking publicly about breast cancer in men.CLM-0006
January 3, 2015Died at his home in Coral Gables, Florida, aged 95.CLM-0008

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Edward William Brooke III was born in Washington, D.C., on October 26, 1919. confirmed BROOKE, Edward William, III. Biographical entry supports
Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) supports
D Brooke was elected attorney general of Massachusetts in 1962 and re-elected in 1964, and in 1966 became the first African American elected to the U.S. Senate by popular vote; he served as a Republican senator from Massachusetts from January 3, 1967, to January 3, 1979. confirmed BROOKE, Edward William, III. Biographical entry supports
Congressional Record, Senate, March 29, 2007: Edward William Brooke III Congressional Gold Medal Act (S. 682) supports
D In a CNN interview aired on June 11, 2003, Brooke said that in September 2002 he felt discomfort in his right breast, which he dismissed as aging, possible muscle strain, or gas; that he then had a mammogram, a sonogram, and a needle biopsy, which found a malignant tumor; that his breasts had never before been examined by a doctor; and that he had not thought men got breast cancer.
His own public account of the delay before seeking care, which the synthetic episode uses as a teaching point. No other detail of his diagnosis is used.
confirmed Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) supports
D In the same interview Brooke said he had to be operated on for breast cancer, that the cancer had spread to his lymph nodes, and that all of the lymph nodes on his right side were removed.
Nodal involvement and an axillary dissection as he described them; the number of nodes was not made public.
confirmed Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) supports
D An Associated Press report of June 11, 2003, said that Brooke, 83, had been diagnosed with breast cancer in September, had a double mastectomy, and was free of the cancer, and that he was encouraging men to examine themselves and urging insurers to cover mammograms for men.
The only fetched source that names the operation. The CNN interview does not contradict it.
confirmed Breast cancer checks urged (Associated Press) supports
Edward Brooke supports
Clemetson L. Surprise Role for Ex-Senator: Male Breast Cancer Patient. The New York Times, June 10, 2003 context
D Brooke said he kept the diagnosis private for several months and then, in June 2003, began speaking publicly about breast cancer in men, saying 'Men have breast tissue like women, and they can have breast cancer, and they do,' and urging men 'not to be so macho about this whole thing'; he called for national awareness, early detection, and insurance coverage of mammograms for men.
The destigmatization message at the center of the record.
confirmed Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) supports
Wingfield S, Pratt M. Groundbreaking Senator Edward W. Brooke dies (Associated Press) supports
BROOKE, Edward William, III. Biographical entry supports
D In the 2003 interview Brooke described himself as not a smoker or a drinker and said he exercised and ate fairly good food.
His own public description, used for the social history.
confirmed Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) supports
D Brooke died at his home in Coral Gables, Florida, on January 3, 2015, aged 95; his former chief counsel said he died of natural causes.
Recorded as a fact; no further detail of his last years is used.
confirmed BROOKE, Edward William, III. Biographical entry supports
Wingfield S, Pratt M. Groundbreaking Senator Edward W. Brooke dies (Associated Press) supports
Edward Brooke, 1st African-American elected to Senate, dies at 95 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Invasive ductal carcinoma of the right male breast, central (retroareolar) portion, stage IIA (pT1c pN1a M0), grade 2, ER positive, PR positive, HER2 negative; treated by bilateral mastectomy and right axillary lymph node dissection; on adjuvant tamoxifen; synthetic modern detail linked to his publicly disclosed breast cancer active confirmed both_with_link CLM-0003, CLM-0004, CLM-0005
S Estrogen receptor-positive status of the breast cancer active confirmed active CLM-0003, CLM-0004, CLM-0005
S Long-term use of tamoxifen, with safety monitoring (venous thromboembolism, mood, hot flashes, sexual side effects, adherence) and bone health review active confirmed active CLM-0003, CLM-0004, CLM-0005
S Absence of both breasts after bilateral mastectomy active confirmed active CLM-0005

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2003-01-13 Hemoglobin [Mass/volume] in Blood 13.8 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2003-01-13 Leukocytes [#/volume] in Blood by Automated count 6.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2003-01-13 Platelets [#/volume] in Blood by Automated count 214 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2003-01-13 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2003-01-13 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2003-01-13 Creatinine [Mass/volume] in Serum or Plasma 1.04 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2003-01-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M 71 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2003-01-13 Calcium [Mass/volume] in Serum or Plasma 9.3 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2003-01-13 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2003-01-13 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 2003-01-13 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 76 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 2003-01-13 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2003-01-13 Albumin [Mass/volume] in Serum or Plasma 4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2003-01-13 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 24 ng/mL (low)
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 2003-01-13 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2003-02-10 DXA Femur [T-score] Bone density -1.2 (low)
Reference -1.0 or higher is normal; -2.5 or lower is osteoporosis
http://loinc.org · 38263-0
S 2003-02-10 DXA Lumbar spine [T-score] Bone density -0.4
Reference -1.0 or higher is normal; -2.5 or lower is osteoporosis
http://loinc.org · 38267-1
S 2003-02-10 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2003-05-12 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 36 ng/mL
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 2003-05-12 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2003-08-11 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2003-10-13 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2003-10-13 Total score [Mini-Cog] 5 http://loinc.org · 72233-0
S 2003-10-13 Total score [AUDIT-C] 0 http://loinc.org · 75626-2
S 2003-10-13 Cholesterol [Mass/volume] in Serum or Plasma 176 mg/dL
Reference <=200 mg/dL
http://loinc.org · 2093-3
S 2003-10-13 Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2003-10-13 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 104 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2003-10-13 Triglyceride [Mass/volume] in Serum or Plasma 92 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8

Synthetic vital signs

DateMeasureResultLOINCGrade
2003-01-13Body height183 cm8302-2S
2003-01-13Body weight81.6 kg29463-7S
2003-01-13Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2003-01-13Systolic blood pressure134 mm[Hg]8480-6S
2003-01-13Diastolic blood pressure76 mm[Hg]8462-4S
2003-01-13Heart rate70 /min8867-4S
2003-01-13Respiratory rate14 /min9279-1S
2003-01-13Body temperature36.6 Cel8310-5S
2003-01-13Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2003-02-10Body height183 cm8302-2S
2003-02-10Body weight81.8 kg29463-7S
2003-02-10Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2003-02-10Systolic blood pressure130 mm[Hg]8480-6S
2003-02-10Diastolic blood pressure74 mm[Hg]8462-4S
2003-02-10Heart rate68 /min8867-4S
2003-02-10Respiratory rate14 /min9279-1S
2003-02-10Body temperature36.7 Cel8310-5S
2003-02-10Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2003-05-12Body height183 cm8302-2S
2003-05-12Body weight82.2 kg29463-7S
2003-05-12Body mass index (BMI) [Ratio]24.5 kg/m239156-5S
2003-05-12Systolic blood pressure128 mm[Hg]8480-6S
2003-05-12Diastolic blood pressure74 mm[Hg]8462-4S
2003-05-12Heart rate66 /min8867-4S
2003-05-12Respiratory rate14 /min9279-1S
2003-05-12Body temperature36.6 Cel8310-5S
2003-05-12Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2003-08-11Body height183 cm8302-2S
2003-08-11Body weight82 kg29463-7S
2003-08-11Body mass index (BMI) [Ratio]24.5 kg/m239156-5S
2003-08-11Systolic blood pressure128 mm[Hg]8480-6S
2003-08-11Diastolic blood pressure72 mm[Hg]8462-4S
2003-08-11Heart rate68 /min8867-4S
2003-08-11Respiratory rate14 /min9279-1S
2003-08-11Body temperature36.7 Cel8310-5S
2003-08-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2003-10-13Body height183 cm8302-2S
2003-10-13Body weight82.4 kg29463-7S
2003-10-13Body mass index (BMI) [Ratio]24.6 kg/m239156-5S
2003-10-13Systolic blood pressure130 mm[Hg]8480-6S
2003-10-13Diastolic blood pressure74 mm[Hg]8462-4S
2003-10-13Heart rate68 /min8867-4S
2003-10-13Respiratory rate14 /min9279-1S
2003-10-13Body temperature36.6 Cel8310-5S
2003-10-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Take tamoxifen every day with side effects managed, aiming to continue for at least five years2003-08-11completedNo missed doses by pill count over seven months; mild hot flashes and a mild fall in libido, both manageable; no clot symptoms
Complete germline genetic testing with counseling, and give him written information for his relatives2003-05-12completedNo pathogenic variant in a multigene panel; family letter given
Establish bone health on hormone therapy at his age: DXA, vitamin D of 30 ng/mL or more, and weight-bearing exercise2003-05-12completedFemoral neck T-score -1.2; vitamin D 36 ng/mL after supplementation
Give a written survivorship care plan with the surveillance schedule2003-08-11completedSurvivorship care plan given at the survivorship visit

Interventions

InterventionStatusGuideline
Medical oncology consultation to take over adjuvant endocrine therapy, confirm that no further adjuvant treatment is needed, and arrange germline genetic testingcompletedGL-ASCO-MBC-2020, GL-NCCN-BREAST-2025
Tamoxifen 20 mg daily for an initial five years, with venous thromboembolism symptoms, mood, hot flashes, sexual side effects, adherence, and interacting medicines reviewed at every visitcompletedGL-ASCO-MBC-2020, GL-CMID-2026
Genetic counseling and germline multigene panel testing (including BRCA2, BRCA1, PALB2, CHEK2, and ATM), with a letter for first-degree relatives explaining the resultcompletedGL-ASCO-MBC-2020, GL-ASCO-SSO-GERM-2024
Bone health: DXA at baseline, vitamin D repletion, dietary calcium, and weight-bearing exercise; bone-modifying drugs only for osteoporosis, not to prevent recurrencecompletedGL-ASCO-MBC-2020, GL-ASCO-BONE-2019, GL-CMID-2026
Survivorship surveillance: cancer-related history and examination of both sides of the chest wall and both axillae every 3 to 6 months for 3 years, then every 6 to 12 months to 5 years, then yearly; no routine imaging, blood tests, or tumor markers without symptoms; lymphedema checkscompletedGL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-MBC-2020
Distress screening at each visit, at least 150 minutes of activity a week, and a written survivorship care plancompletedGL-ACS-ASCO-SURV-2016, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 BROOKE, Edward William, III. Biographical entry U.S. House of Representatives: History, Art & Archives government
SRC-0002 Male Breast Cancer. American Morning, interview with former Senator Edward Brooke (transcript) CNN primary
SRC-0003 Congressional Record, Senate, March 29, 2007: Edward William Brooke III Congressional Gold Medal Act (S. 682) U.S. Government Publishing Office (govinfo) government
SRC-0004 Breast cancer checks urged (Associated Press) Sun Journal (Lewiston, Maine) other
SRC-0005 Wingfield S, Pratt M. Groundbreaking Senator Edward W. Brooke dies (Associated Press) The Christian Science Monitor other
SRC-0006 Edward Brooke Wikipedia other
SRC-0007 Clemetson L. Surprise Role for Ex-Senator: Male Breast Cancer Patient. The New York Times, June 10, 2003 The New York Times other
SRC-0008 Edward Brooke, 1st African-American elected to Senate, dies at 95 CBS News other
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the omission of chemotherapy and radiation at 83, the tamoxifen monitoring, and the bone-health plan.
provenance reviewnot_startedRecent-death rule: only what Brooke said publicly (a 2003 CNN interview and Associated Press reports) and basic biographical facts are used. No physician of his made a public statement that was found. Statements about his relatives in the news reports are not used.
safe messaging reviewnot_startedBreast cancer in a man is described plainly, without any framing of it as embarrassing; no behavioral-health diagnosis; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.